MOHAN PANKAJ (Chairman, President and CEO) purchased 204.5% of their position (371.60K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $82.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/15/2023ACC: 0001493152-23-017528
DirectorOfficer· Chairman, President and CEO
Since Apr 2020
+371.60K
Net shares
Net buyer
$82.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
371.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+371.60K
Price / share
$0.22
Trade value
$82.87K
% of position
204.5%
5/15/2023
181.73K→553.33K
Total
Net shares
+371.60K
Net value
$82.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2023 | P · Purchase | +371.60K | $0.22 | $82.87K | 204.5% | 181.73K | 553.33K |
| Total | +371.60K | $82.87K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned570.00
Common Stock
IndirectShares owned66.48K
Total
67.05K indirect67.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 570.00 | Indirect |
| Common Stock | 66.48K | Indirect |
| Total | 67.05K | 67.05K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported